In this special report, the editors of Med Ad News and R&D Directions provide information about prescription drugs in development in the United States.
This report contains five sections that separate the drugs by their approved or development status. The five sections are: Approved medicines, Awaiting Approval, Phase III Clinical Trials, Phase II Clinical Trials, and Phase I Clinical Trials.
Each section lists the drugs in alphabetical order by product name. Each grouping within the lists provides the commercial name of the product if already given, the chemical or substance composition of the product when available, approved indication or intended indication of the product, the developer of the product, and the website of each developer.
This PDF report is completely searchable via Adobe Acrobat Reader.